NEW YORK (GenomeWeb News) – British science services firm LGC today said that it has licensed Abbott's Ibis T5000 Biosensor System and will work with Abbott to develop commercial applications for the molecular diagnostics platform.

Under terms of the alliance, the partners will jointly identify and develop commercial diagnostic applications for the T5000, which is currently sold for research uses. LGC received an exclusive license to develop non-clinical applications in the UK and a non-exclusive license to develop clinical and food-testing applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.